Skip to content

Zephyr® Endobronchical Valves:

Optimizing Outcomes in Bronchoscopic
Lung Volume Reduction Procedures

Designed for current bronchoscopic lung volume practitioners, a panel of BLVR experts will discuss their individual approaches to a variety of clinical challenges, including treating homogenous patients, pneumothorax mitigation and treatment, and their evolving patient selection criteria in the post-LIBERATE era.

Register

"*" indicates required fields

Name*
Location*
Would you like to receive additional information from Pulmonx about other events and product information?*
By submitting this form, I consent to Pulmonx Corporation (“Pulmonx”) and its third-party vendors using the information I have provided to contact me (via phone, email or text) with information regarding its products, inform me regarding various news, events and research studies and to allow Pulmonx to use this information for additional purposes identified in its Privacy Policy.
Hidden
MM slash DD slash YYYY
This field is for validation purposes and should be left unchanged.

Alma Gaucha Restaurant

Tuesday, October 8, 2024, 6:30 – 8:30 p.m.

401 D Street, Boston, MA 02210

Dinner will be provided*
2Kurman-High-Res

Jonathan Kurman,
MD, MBA

Director, Interventional Pulmonology
Froedtert & Medical College of Wisconsin
Milwaukee, WI

Amit-Bobby-Mahajan-MD-FCCP-DAABIP

Amit “Bobby” Mahajan,
MD, FCCP, DAABIP

Medical Director, Interventional Pulmonology & Complex Airway
Disease Program
Inova Fairfax Hospital
Fairfax, VA

Kevin-Ma

Kevin Ma, MDP

Medical Director, Interventional Clinical Director, Bronchoscopic Lung Volume Reduction Program
Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care), University of Pennsylvania
Philadelphia, PA


*Pulmonx Corporation is required to report transfers of value (e.g. meals) related to this educational
event in compliance with the Sunshine Act.

Speakers are paid consultants of Pulmonx Corporation.

© 2023-Present Pulmonx Corp or its affiliates. All rights reserved. All trademarks herein are the property of Pulmonx Corporation and its affiliates.
US-EN-1986-v1